| 摘要 |
<p>The present invention relates to a pharmaceutical composition comprising at least one polypeptide selected from the group consisting of (a) a polypeptide encoded by a polynucleotide comprising a nucleic acid sequence as defined herein; (b) a polypeptide comprising an amino acid sequence as defined herein; (c) a polypeptide which is or which comprises a functional domain, an antigenic fragment and/or a fragment capable of eliciting and/or triggering an immune response in a mammal of the polypeptide of(a) or (b); (d) a polypeptide which is encoded by a polynucleotide which is at least 80 % identical to the polynucleotide as defined in (a) and which is capable of eliciting and/or triggering an immune response in a mammal; and (e) a polypeptide which is encoded by a polynucleotide which hybridizes under stringent conditions with the polynucleotide as defined in (a) or (d) and is capable of eliciting and/or triggering an immune response in a mammal. Furthermore, the invention provides for pharmaceutical compositions comprising fusion proteins, polynucleotides, vector(s), host cell(s) or antibodies as described herein. In addition, the invention relates to recombinant (bacterial) host cells and methods for the production of a vaccine.</p> |
